2.30

4.55% 0.10

After Hours: 2.30

Vivos Therapeutics Inc (VVOS)

Overview News Price History Financials Discussions Forecast Stock Split

Vivos Therapeutics Inc stock is traded at $2.30, with a volume of 86,150. It is up +4.55% in the last 24 hours and down -36.11% over the past month. Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Previous Close:

$2.20

Open:

$2.2189

24h Volume:

86,150

Relative Volume:

0.58

Market Cap:

$12.90M

Revenue:

$14.58M

Net Income/Loss:

$-12.57M

P/E Ratio:

-0.4049

EPS:

-5.68

Net Cash Flow:

$-13.07M

1W Performance:

+5.02%

1M Performance:

-36.11%

6M Performance:

-12.55%

1Y Performance:

-12.88%

1-Day Range:

$2.2189

$2.40

1-Week Range:

$1.98

$2.40

52-Week Range:

$1.91

$6.28

Vivos Therapeutics Inc Stock (VVOS) Company Profile

Name

Vivos Therapeutics Inc

Sector

Healthcare (1153)

Industry

Medical Devices (154)

Phone

(866)908-4867

Address

7921 SOUTHPARK PLAZA,, LITTLETON

Employee

109

Twitter

Next Earnings Date

2025-03-31

Latest SEC Filings

VVOS's Discussions on Twitter

Compare VVOS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VVOS Vivos Therapeutics Inc	2.30	12.90M	14.58M	-12.57M	-13.07M	-5.68
ABT Abbott Laboratories	131.73	218.91B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	95.05	139.37B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	348.12	134.90B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	83.37	106.90B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	70.60	41.45B	5.72B	4.17B	259.90M	6.97

Vivos Therapeutics Inc Stock (VVOS) Latest News

Apr 16, 2025

Vivos Therapeutics to acquire operating assets of The Sleep Center of Nevada - MSN

Apr 16, 2025

Vivos Therapeutics announces agreement to acquire operating assets of SCN - TipRanks

Apr 16, 2025

Vivos To Acquire Operating Assets Of The Sleep Center Of Nevada - Nasdaq

Apr 16, 2025

Vivos Therapeutics Signs Definitive Agreement To Acquire Largest Sleep Center Operator In Nevada - marketscreener.com

Apr 16, 2025

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada - The Manila Times

Apr 16, 2025

Major Healthcare Expansion: Vivos Takes Over Nevada Sleep Giant Serving 3,000 Monthly Patients - Stock Titan

Apr 16, 2025

Apr 12, 2025

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Report on Q2 2024 Financial Results, Operational Update - MSN

Apr 12, 2025

Apr 11, 2025

Commonwealth Equity Services LLC Buys 5,000 Shares of Vivos Therapeutics, Inc. (NASDAQ:VVOS) - Defense World

Apr 11, 2025

Apr 05, 2025

Positive Sentiment Still Eludes Vivos Therapeutics, Inc. (NASDAQ:VVOS) Following 26% Share Price Slump - simplywall.st

Apr 05, 2025

Apr 03, 2025

Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress - ACCESS Newswire

Apr 03, 2025